Wk 10: Sympathomimetic agents Flashcards

(108 cards)

1
Q

Naturally occurring catecholamines (3)

A

Epinephrine
Norepinephrine
Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Synthetic catecholamines (2)

A

Isoproterenol
Dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epinephrine is a hormone synthesized, stored, and released from the _______ _______

A

adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epinephrine’s natural functions upon release into circulation include (5)
-Regulation myocardial _______
- _________ _________
-_____ and ____ smooth muscle tone
-________ secretions
-Metabolic processes (______ and ______)

A

-Regulation myocardial contractility
-Heart rate
-Vascular and bronchial smooth
muscle tone
-Glandular secretions
-Metabolic processes
(glycogenolysis and lipolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epinephrine receptors

A

Alpha 1
Alpha 2
Beta 1
Beta 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why isn’t oral administration of epinephrine effective?

A

Rapid metabolism in GI mucosa and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What routes can epinephrine be administered?

A

Subcutaneous
IM
IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epinephrine is poorly _______ soluble, preventing its ready entrance into the _____ ______ _____ and accounting for the lack of _______ _______

A

lipid
central nervous system
cerebral effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epinephrine clinical uses:

-___________
-Severe ________ and _______
-Cardiopulmonary __________
-Promotion of myocardial ________ and increase __________ ________
-Can be added to LA as a “marker” or to decrease _______ absorption and prolong DOA

A

-Anaphylaxis
-asthma and brochoconstriction
-Cardiopulmonary resuscitation
-promotion of myocardial contractility and increase vascular resistance
-systemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

____________ has the most significant metabolic effect on metabolism of all the catecholamines

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Release of endogenous epinephrine and the resulting __________ and inhibition of _______ secretion is the most likely explanation for perioperative hyperglycemia

A

glycogenolysis
insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coagulation is accelerated by _________

A

epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A hypercoagulable state present during the intraoperative and postoperative period may reflect stress-associated release of _________

A

epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Norepinephrine is the endogenous neurotransmitter synthesized and stored in __________ sympathetic nerve endings and released with sympathetic nerve stimulation

A

postganglionic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Norepinephrine receptors

A

Alpha 1 > B1

B2 (weak)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The primary utility of norepinephrine is as a potent ________ to increase total peripheral vascular resistance and mean arterial pressure

A

vascoconstrictor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is first-line agent in the treatment of refractory hypotension during severe sepsis?

A

Norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Norepinephrine-induced vasoconstriction and redistribution of flow may increase ________ blood flow and _______ _______ in severely hypotensive septic patients

A

splanchnic
urine output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Norepinephrine side effects

Use as an inotropic agents limited by its action as a ___________ _________

A

potent vasoconstrictor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Norepinephrine side effects

Excessive vasoconstriction and decreased perfusion of renal, splanchnic, and peripheral vascular beds may lead to end-organ _______ and ________

A

hypoperfusion
ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

__________ is an endogenous catecholamine that regulates cardiac, vascular, and endocrine function.

Is an important neurotransmitter in the central and peripheral nervous systems

A

Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Despite identical IV infusion rates, there may be a ___ to ____ -fold variability in plasma concentrations produced by this drug, even in healthy individuals with normal drug metabolism

A

Dopamine

10-75

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dopamine receptors

A

B1 > B2
Alpha 1
D1 D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dopamine increases cardiac output by stimulation of ____ receptors, increasing ______ ______

A

Beta 1
stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Rapid metabolism of dopamine with an elimination half life of ___ to ___ minutes mandates its use as a continuous infusion
1 to 2 minutes
26
______________ is used clinically to increase cardiac output in patients with decreased contractility, low systemic BP, and low urine output as may be present after cardiopulmonary bypass or with chronic heart failure
Dopamine
27
Dopamine is unique among the catecholamines in being able to simultaneously: -Increase myocardial _________ -Increase ________ blood flow -Increase ________ _________ rate -Excretion of _________ -Increase __________ output
contractility renal glomerular filtration sodium urine
28
Which catecholamine is associated most with dose-related sinus tachycardia and the potential to cause ventricular arrhythmias?
Dopamine (vs. dobutamine or epinephrine)
29
Dopamine may presdispose to mycardial ischemia by: precipitating ________, increasing ________, increasing _______, and precipitating coronary artery _________
tachycardia contractility afterload vasospasm
30
__________ is the most potent activator of all sympathomimetics with beta 1 and beta 2 activity ____ to ____ times more potent than epinephrine and at least _____ times more active than NE
Isopreterenol 2 to 3 100
31
Isoproterenol receptors
Beta 1 Beta 2
32
The cardiovascular effects of isoproterenol reflect activation of beta 1 receptors in the ______ and beta 2 receptors in the _______ _______
heart skeletal muscle
33
Isoproterenol Although cardiac output may increase, the ___________ may decrease
Mean arterial pressure (MAP)
34
Does baroreceptor-mediated reflex bradycardia occur with isoproterenol?
No because MAP is not increased
35
Metabolism of isoproterenol in the _______ by catechol-O-methyltransferase is ________, necessitating a continuous infusion to maintain therapeutic plasma concentrations
liver rapid
36
_________ is used to increase heart rate in adults in presence of heart block
Isoproterenol
37
_________ is used to provide sustained increases in heart rate before insertion of a temporary or permanent cardiac pacemaker
Isoproterenol
38
___________ is a synthetic catecholamine derived from isoproterenol consisting of a 50:50 racemic mixture of two sterioisomers
Dobutamine
39
Dobutamine receptors
Beta 1 > Beta 2 Alpha (high doses)
40
Dobutamines effects on ____ receptors increases at higher doses
alpha
41
_________ stimulates SA node automaticity as well as AV node and ventricular conduction
Dobutamine (tachyarrhythmias)
42
Rapid metabolism of dobutamine (half life ___ mins) necessitates continuous infusion
2 mins
43
Dobutamine increases myocardial contractility (____ and ______ receptors) and causes a modest degree of peripheral vasodilation ( _____ receptors)
Beta 1 and alpha 1 Beta 2
44
Dobutamine is used to : (2)
-improve cardiac output in patients with CHF -Weaning from CPB
45
Vasodilators may be combined with ________ or _________ to decrease afterload, optimizing cardiac output in the presence of increased _______
dobutamine dopamine SVR
46
The use of dobutamine may be limited by the occurrence of ________
tachyarrhythmias
47
Tachyarryhthmias in dobutamine occur more frequently at ______ _____ or in patients with underlying _______ or _______ _________
higher doses arrhythmias heart failure
48
Synthetic noncatecholamines
Ephedrine Phenylephrine
49
_________ is an indirect and direct acting synthetic sympathomimetic Indirect: stimulates release of endogenous ____ Direct: stimulates ___ and ___ -adrenergic receptors
Ephedrine NE alpha and beta
50
The slow inactivation and excretion of ________ are responsible for the prolonged duration of action of this sympathomimetic
ephedrine
51
Ephedrine uses: -Increase BP in presence of SNS blockade produced by _____ _____ -Hypotension due to _______-or _________ anesthetics
regional anesthesia inhaled or injected anesthetics
52
__________ was considered the preferred sympathomimetic for administration to parturients experiencing decreased systemic blood pressure owing to spinal or epidural anesthesia alpha agonists such as __________ may be preferable for treatment of maternal hypotension
Ephedrine Phenylephrine
53
Cardiovascular effects of ephedrine resemble those of __________, its systemic BP-elevating response is ________ ________ and lasts approximately ____ times longer
epinephrine less intense 1o
54
IV ephedrine results in increases in: (3)
-Sys. and dys. BP -HR -CO
55
Ephedrine receptors
Alpha 1 Beta 1 > Beta 2
56
Phenylephrine receptor
Alpha 1
57
The principle mechanism for cardiovascular effects produced by ephedrine is increased myocardial _________ due to activation of ___ receptors
contractility B1
58
In the presence of ______________, the cardiovascular effects of ephedrine may resemble responses more typical of alpha-adrenergic receptor stimulation
preexisting beta-adrenergic blockade
59
A second dose of ephedrine produces a less intense systemic blood pressure response than the first dose (_______________, occurs with many sympathomimetics
tachyphylaxis
60
___________ mimics the effects of NE but is less potent and longer lasting
Phenylephrine
61
Phenylephrine stimulates ____ receptors by a direct effect, with only a small part of the pharmacologic response being indirect-acting d/t its ability to evoke the release of ________
alpha 1 NE
62
Phenylephrine primarily causes ________ rather than ________ constriction
venoconstriction
63
Phenylephrine uses: -Increase BP in presence of SNS blockade produced by _____ _____ -Peripheral vasodilation due to _______-or _________ anesthetics -As a _________ infusion in adults to maintain normal BP during surgery
regional anesthesia inhaled or injected anesthetics continuous
64
Selective Beta 2- adrenergic agonists (3)
Albuterol Metaproterenol Terbutaline
65
Selective phophodiasterase inhibitors
Milrinone Amrinone
66
Selective beta 2 agonists relax ________ and _______ smooth muscle, but in contrast to isopreterenol generally lack stimulating ____ effects on the heart
bronchiole and uterine B1
67
Which of the beta 2 agonists can be administered MDI, PO, and subcutaneously?
Terbitaline
68
_______ are the preferred treatment for acute episodes of asthmas and the prevention of exercise-induced asthma
Beta 2 adrenergic agonists
69
Beta 2 agonists are divided into those with an intermediate DOA ( ___ to ___ hours) and those that are long acting (>___ h)
3-6 12
70
Beta-2 adrenergic agonists may be administered as continuous infusions to stop _______ _______ ______ (_______ )
premature uterine contractions (tocolytics)
71
Beta-2 adrenergic bronchodilators can be administered (4)
Orally Inhalation Subcutaneously IV injection
72
The _________ route for beta 2 agonist bronchodilators is the preferred route because the side effects are fewer for any degree of bronchodilation
inhaled
73
With optimal inhalation technique approximately ___% of alpha 2 agonists is delivered from the MDI to the lungs, the remainder is deposited in the mouth, pharynx, and larynx
12%
74
Technique for administering beta 2 agonist with MDI Discharge inhaler while taking a slow deep breath over ___ to___ seconds, and then hold the breath at full inspiration for ___ seconds
5 to 6 10
75
Beta 2 agonist The presence of an ETT decreases by approximately ___% to ____% the amount of drug delivered by a MDI that reaches the trachea
50-70
76
Beta 2 agonist Actuation of the MDI during a mechanically delivered __________ increases the amount of drug that passes beyond the distal end of the tracheal tube
inspiration
77
Side effects of Beta 2 agonists The widespread distribution of beta 2 adrenergic receptors makes it likely that undesired responses result when beta 2 adrenergic agonists undergo ___________ absorption
systemic
78
The principle side effect in awake subjects of beta 2 adrenergic agonists treatments is ________
tremor
79
Increased _________ _______ is less common with the selective beta 2 adrenergic agonists
heart rate
80
In patients with acute, severe ________, beta 2 agonists may cause transient decrease in ________ ______ presumed to reflect relaxation of compensatory _________ in areas of deceased ventilation
asthma arterial oxygenation vasoconstriction (supplemental oxygen indicated)
81
Acute metabolic responses to beta 2 adrenergic agonists include: (3)
Hyperglycemia Hypokalemia Hypomagnesemia
82
_________ is the preferred selective beta 2 adrenergic agonist for the treatment of acute bronchospasm due to asthma
Albuterol
83
Administration of albuterol is most often by a MDI, producing about ______ mcg per puff
100
84
The duration of action of inhaled dose of Albuterol is about ___ hours, but significant relief of symptoms may persist up to ___ hours
4 8
85
The effects of Albuterol and volatile anesthetics on bronchomotor tone are ________
additive
86
___________ is a predominantly beta 2 adrenergic agonist that may be administered ______, _______, or by _______ to treat asthma
Terbutaline orally subcutaneously inhalation
87
The subcutaneous administration of terbutaline ( _____mg) produces responses that resemble those of _______, but the duration of action is _________
0.25 epinephrine longer
88
Phosphodiesterase inhibitors are a heterogenous group of ____________ ____________ compounds that exert a competitive inhibitory action on phosphodiesterase enzymes
noncatecholamine nonglycoside
89
The PDE III inhibitors have their greatest clinical usefulness in patients who would benefit from combined ______ and _______ therapy
inotropic vasodilatory
90
___________ is a derivative of amrinone with almost ____ times the inotropic potency of amrinone but less adverse effects
milrinone 30
91
Because of its reduced incidence of side effects, ________ has replaced amrinone in clinical use
milrinone
92
PDE III inhibitors Cardiac output improves both as a result of increased ________ as well as vascular smooth muscle relaxation of _________ and ________ vessels
inotropy peripheral and pulmonary
93
Milrinone may be useful in management of acute _______ _______ dysfunction
left ventricular
94
Milrinone can be useful when weaning high-risk patients from ____________ ____________
cardiopulmonary bypass
95
Milrinone may potentiate the effects of ________ agents as well as help increase inotropy in chronic heart failure patients who have downregulation of _____ adrenergic receptors
adrenergic beta 1
96
Milrinone is useful in the setting of _______ __________ decreases _______ _______ pressures more effectively than other positive inotropic drugs
pulmonary hypertension pulmonary artery
97
Milrinone is associated with more ________ and greater decrease in _______ and ______ than dobutamine
vasodilation SVR BP
98
Unlike dobutamine, milrinone rarely causes __________
tachycardia
99
Milrinone may be preferred in situation with high _______ _______, elevated _______ _______ pressure, need for continued _____ blockade, decreased responsiveness to ________ therapy, and increased risk for _________________
filling pressures pulmonary artery beta catecholamine tachyarrhythmias
100
Rapid administration of milrinone may decrease ________, decrease ________, and result in hypotension May also be associated with arrhythmias due to enhanced ____ node conduction
SVR venous return AV
101
______ is present in the body in greater amounts than any other mineral
calcium
102
Calcium is important for -__________ transmission -________ _______ contraction -________ _______ contractility -Blood ___________ _ ___________ necessary for release of neurotransmitters
neuromuscular skeletal muscle cardiac muscle coagulation exocytosis
103
Calcium is the principal component of ________
bone
104
Calcium is a potent _________-
inotrope
105
Increasing the plasma concentrations of ionized calcium with exogenous administration of calcium chloride or calcium gluconate is commonly used to treat cardiac depression as may accompany: -delivery of ________ ________ -transfusion of ________ blood -following termination of _______ _____
volatile anesthetics citrated cardiopulmonary bypass
106
Ionized calcium typically represents approximately ___ % of the total plasma concentration
45%
107
Acidosis ______ ionized calcium Alkalosis _____ ionized calcium
increases decreases
108
Normal plasma ionized calcium (3)
1-1.26 mmol/L 2-2.5 mEq/L 4-5mg/dL